Mr. Dan Barnea is the former Senior Vice President, R&D and Strategy and Corporate Development of BMC Software. Prior to his role at BMC Software Barnea served as CEO of New Dimension Software, managing its international growth and development until it was acquired by BMC for $673M. MR. Barnea has held additional senior management positions in technology companies including CEO of Laser Industries, general manager of Indigo (acquired by HP for $830M), and vice president of research and development for Elscint (activities sold to GE Healthcare and Philips Medical Systems). Barnea holds a BSc. (Electrical Engineering) and MSc. (Computer Science) from the Technion – Israel Institute of Technology, and is currently active chairman of Final Inc. a world leader in high-frequency electronic trading.
Barnea is also an active investor in ScaleMP.
Mr. Yoav Chelouche is a Managing Partner at Aviv Venture Capital. He brings to Aviv Venture Capital twenty years of experience in management, initiation and investments in the global high-tech arena. Prior to Aviv, Chelouche served as President & CEO of Scitex corp. (previously NASDAQ: SCIX) a world leader in digital imaging and printing systems with $700M in revenue and 4,000 employees) and was Chairperson of publically listed DMAtek which was sold to Francisco partners at a 90% premium over public market price. Chelouche serves on the boards of Checkpoint Technologies (NASDAQ:CHKP) and the Tel-Aviv Stock Exchange and until recently was the Co-Chair of IATI-Israel Advanced Technology Industries (Israel’s largest umbrella organization for the high tech and life science industries). Chelouche holds an MBA from INSEAD, Fontainebleau, France 1979 (Winner of Henry Ford Prize for first in class) and a BA in Economics and Statistics from Tel Aviv University, Israel.
Dr. Ram Vromen is the Managing Partner of Evolution Venture Capital Fund. Previously he was a partner at Millennium Materials Technologies Fund, a venture capital fund focused on material sciences, and prior to that, a managing director of First IsraTech Fund, a venture capital fund focused primarily on medical devices. Before embarking on his VC career Vromen was a corporate lawyer focused on the hi-tech and venture capital practice. Ram serves as Chairman of WhiteSmoke Software Ltd. listed on TASE and has been a board member in over 20 private hi-tech companies in the past 15 years, with an investment track record that includes multiple exits such as the listings of Enzymotec and Perion (Incredimail) on Nasdaq, SightLine acquired by Stryker, Cadent acquired by Align Technology Inc. and OreX acquired by Kodak. Ram has a PhD in history from the Ecole Des Hautes Etudes en Sciences Sociales, Paris, France and an LLB in law from Tel Aviv University.